Fluorescence switchable sensor enabled by a calix[4]arene-Cu(II) complex system for selective determination of itraconazole in human serum and aqueous solution

A switchable fluorescence sensor based on a calix (Monapathi et al., 2021) [4]arene:Cu²⁺ complex (FLCX/Cu) has been developed for the detection of itraconazole (ITZ) with high sensitivity and specificity. For the development of the sensor, the selective complexation of a fluorescent calix (Monapathi et al., 2021) [4]arene derivative (FL-CX) with the Cu²⁺ ion causing fluorescence quenching was utilized. In addition, the sensor properties of the FLCX/Cu prepared were investigated. For this purpose, various substances (selected anions, cations, and drugs) with which ITZ can be found together were studied in an aqueous solution. Limit of detection (LOD) and limit of quantification (LOQ) values were determined in the range of 1.00-60.0 μg/L as 3.34 μg/L and 11.1 μg/L for ITZ, respectively. Moreover, the real sample analyses were performed in human serum and tablet form. Furthermore, the effect of some possible serum contents on sensor performance was also studied. All these studies confirmed the development of a simple, precise, accurate, reproducible, highly sensitive, and very stable fluorescence sensor.

Factorial design-assisted reversed phase-high performance liquid chromatography method for simultaneous determination of fluconazole, itraconazole and terbinafine

A 23 full factorial design model was used for the development of a new high performance liquid chromatography method with UV detection to estimate three antifungal drugs simultaneously. Fluconazole (FLU), itraconazole (ITR) and terbinafine (TRH) are co-administered for severe fungal infections. They have been determined using MOS-1 Hypersil C18 column and an isocratic eluent; methanol 95% and phosphate buffer 5% with 0.001% triethylamine. The pH was adjusted to 7, and the flow rate was 0.7 ml min-1. The three drugs were separated within less than 7 min at 210 nm. The developed method gave a linear response over 5-80 µg ml-1, 5-50 µg ml-1 and 1-50 µg ml-1 for FLU, ITR and TRH, respectively. It showed detection limits of 0.88, 0.29 and 0.20 µg ml-1 and quantification limits of 2.66, 0.88 and 0.60 µg ml-1 for the three drugs, respectively. The design of the experiment facilitated the optimization of different variables affecting the separation of the three drugs. The sensitivity of the designed method permitted the simultaneous estimation of ITR and TRH in spiked human plasma successfully.

Combining derivative and synchronous approaches for simultaneous spectrofluorimetric determination of terbinafine and itraconazole

In this study, determination of terbinafine and itraconazole down to biological concentration level has been carried out. The determination is based on increasing the selectivity of the spectrofluorimetric technique by combining both derivative and synchronous spectrofluorometric approaches, which permits successful estimation of terbinafine at 257 nm and itraconazole at 319 nm in the presence of each other at Δλ of 60 nm. International Conference on Harmonization validation guidelines were followed to fully validate the method, and linearity was obtained for the two drugs over the range of 0.1-0.7 µg ml-1 for terbinafine and 0.5-4.0 µg ml-1 for itraconazole. Application of the method was successfully carried out in the commercial tablets with good agreement with the comparison spectrofluorometric methods. As the detection limits were down to 0.013 and 0.1 µg ml-1 and quantitation limits were 0.04 and 0.032 µg ml-1 for terbinafine and itraconazole, respectively; the in vitro determination of terbinafine and itraconazole in spiked plasma samples was applicable. The percentage recoveries in biological samples were 97.17 ± 4.54 and 98.75 ± 2.25 for terbinafine and itraconazole, respectively. Water was used as the optimum diluting solvent in the proposed methodology which adds an eco-friendly merit.

A sustainable approach for graphene-oxide surface decoration using Oxalis corniculata leaf extract-derived silver nanoparticles: their antibacterial activities and electrochemical sensing

In this work, a facile green synthesis using Oxalis corniculata leaf extract (OCLE) as a biodegradable reducing and capping/stabilizing agent was carried out for the construction of Oxalis corniculata leaf extract-derived silver nanoparticles (OCLE-AgNPs). Moreover, OCLE-AgNPΔGO nanocomposites were fashioned simply by mixing a GO suspension and supernatant OCLE-AgNPs via a one-pot environmentally benign method. The AgNPΔGO nanocomposites are biocompatible materials for potential applications such as antibacterial activities against two different types of bacterial cells, namely Gram-positive Bacillus subtilis and Gram-negative Escherichia coli and selective electrochemical sensing to itraconazole (ITRA) at the fabricated GCE (AgNPΔGO@GCE). AgNPΔGO@GCE sensors gave excellent outcomes for ITRA as higher current response over the bare GCE. Under optimized conditions, the oxidation peak current of ITRA varied linearly with a wide range of the concentration between 26.7 μM and 103.8 μM with a correlation coefficient of 0.997 and a detection limit of 0.1276 μM, for differential pulse anodic stripping voltammetric (DP-ASV) technique. In addition, the possible mechanism for the ITRA oxidation was further verified and explained by single-electron transfer (SET) and proton removal mechanism steps. The developed sensor exhibited good repeatability, reproducibility, and stability. The use of environmentally benign and renewable plant material offers enormous benefits of eco-friendliness applicability.

Stability-indicating high-performance thin-layer chromatographic method for analysis of itraconazole in bulk drug and in pharmaceutical dosage form

Background:

A new, simple, selective, precise, and stability-indicating high-performance thin-layer chromatographic method has been established for analysis of itraconazole (ITZ) in the bulk drug and in pharmaceutical formulations. Separation was achieved on aluminium plate precoated with silica gel 60F254 using Toluene : Chloroform : Methanol [5 : 5 : 1.5 (v/v)] as mobile phase. Densitometric analysis was performed at 260 nm.

Result:

Compact bands of ITZ were obtained at R_f 0.52 ± 0.02. Linearity (R² = 0.9978), limit of detection (180.29 ng/band), limit of quantification (546.34 ng/band), recovery (98–102%), and precision (≤0.51%) were satisfactory. Drug was not degraded under neutral and alkaline hydrolysis, UV and photolytic degradation, under-elevated temperature, and humidity. ITZ is degraded under acidic hydrolysis and oxidative condition; the degraded products were well resolved from individual bulk drug response. Developed method can effectively resolve drug from its excipients in capsule dosage form. The specificity of the method was confirmed by peak purity of resolved peak.

Conclusion:

The method can be applicable for routine analysis of ITZ in pharmaceutical formulation as stability-indicating. Because the method can effectively separate the drug from its degradation products as well as excipients, it can be used as a stability-indicating method.